# Effect of Olivomed (Olive Extract) on Endothelial, Cardiac and Vascular Function

> **NCT04520126** · NA · RECRUITING · sponsor: **University of Athens** · enrollment: 30 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Olivomed (capsules containing hydroxytyrosol)
- **DIETARY_SUPPLEMENT:** OlivomedSmart - Capsules containing - combination of Oleuropein (OL), Hydroxytyrosol (HT), Oleocanthal (OC) - (OL:HT:OC 2:1:3), (5 mg HT bid).

## Key facts

- **NCT ID:** NCT04520126
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-01
- **Primary completion:** 2025-04-10
- **Final completion:** 2026-08-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04520126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04520126, "Effect of Olivomed (Olive Extract) on Endothelial, Cardiac and Vascular Function". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04520126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*